Cancer researcher develops targeted pediatric cancer drugs

unc.edu

Cancer researcher Samantha Pattenden's lab is developing more targeted pediatric cancer drugs. Her work focuses on chromatin, the structure packaging DNA, and how its accessibility drives cancer growth. This research aims to create treatments with fewer side effects. Pattenden's lab is investigating compounds for Ewing sarcoma and other aggressive pediatric cancers, collaborating with oncologists and scientists to find new therapeutic targets.


With a significance score of 4.4, this news ranks in the top 3.3% of today's 28734 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Cancer researcher develops targeted pediatric cancer drugs | News Minimalist